Previous 10 | Next 10 |
World Copper (WCUFF) is expected to report $-0.01 for Q2 2023 GlassBridge Enterprises Inc (GLAE) is expected to report for quarter end 2023-06-30 Paladin Energy Ltd (PALAF) is expected to report for Q4 2023 Andritz AG ADR (ADRZY) is expected to report for Q2 2023 Cincinnati Bancor...
2023-09-12 12:52:44 ET Gainers: Anebulo Pharmaceuticals ( ANEB ) +35% . WeWork ( WE ) +34% . Shengfeng Development Limited ( SFWL ) +29% . AEON Biopharma ( AEON ) +28% . Avalo Therapeutics ( AVTX ) +28% . The Beauty Health Co...
Anebulo Pharmaceuticals Inc. (ANEB) is expected to report for Q4 2023 Minera IRL Ltd ADR (MRLLY) is expected to report for Q3 2023 OpenLocker Holdings Inc (OLKR) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-0.43 for Q2 2024 Sompo Holdings I...
Anebulo Pharmaceuticals Inc. (ANEB) is expected to report for Q4 2023
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse (the “Company” or “Anebulo”), today announced that it will be giving...
FDA provides favorable input on studies to support ANEB-001 approval Part C Extension of Phase 2 trial completed exploring THC challenge dose of up to 60 mg Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (the “Company” or “Anebulo”), a clinical-stag...
NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subje...
2023-05-11 12:17:22 ET Anebulo Pharmaceuticals press release ( NASDAQ: ANEB ): Q1 GAAP EPS of -$0.11. Cash was $14.2 million as of March 31, 2023. For further details see: Anebulo Pharmaceuticals GAAP EPS of -$0.11
Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates PR Newswire AUSTIN, Texas , May 11, 2023 /PRNewswire/ -- Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel s...
Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication PR Newswire ANEB-001 statistically significantly reduced VAS Feeling High in all cohorts (p=<0.0001 at the 30 mg...
News, Short Squeeze, Breakout and More Instantly...
Anebulo Pharmaceuticals Inc. Company Name:
ANEB Stock Symbol:
NASDAQ Market:
Anebulo Pharmaceuticals Inc. Website:
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), has been awarded the first tranche of a two year cooperati...
CHASKA, Minn., July 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced it has reached a cooperation agreemen...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.2% to $126.57 on volume of 604,432,871 shares American Rebel Holdings Inc. (AREB) rose 152.5% to $0.76 on volume of 367,740,589 shares Sirius XM Holdings Inc. (SIRI) rose 1.0% to $2.93 on volume of 329...